Breaking New Ground in Synovial Sarcoma: Choy on the FDA Approval of Afami-cel

Headliner Embed

Embed code See more options

Share

Facebook X

Subscribe

In this episode of Targeted Talks, Edwin Choy, MD, PhD, discussed the FDA approval of afamitresgene autoleucel for the treatment of patients with advanced synovial sarcoma.

Share

Facebook X

Subscribe

Next

Tarantino Covers HER2-Low Breast Cancer and Antibody-Drug Conjugates

Top episodes

Individualizing Immunotherapy in Non–Small Cell Lung Cancer

by Treating Together

Modern Strategies Improving Immunotherapy in Cancer

by Treating Together

Therapies on the Horizon in EGFR Exon 20–Positive Lung Cancer

by Treating Together

•   Report this episode
•   Download audio
•   QRCode